TSH-secreting adenomas

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 23, Issue 5, 2009, Pages 597-606

  Beck Peccoz, Paolo ^a   Persani, Luca ^b   Mannavola, Deborah ^a   Campi, Irene ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

pituitary glycoprotein hormone subunit ( GSU); resistance to thyroid hormones; somatostatin analogues (octreotide, lanreotide); thyroid hyperfunction; thyrotropin (thyroid stimulating hormone, TSH); TSH induced; TSH secreting pituitary adenomas (TSHomas)

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; LIOTHYRONINE; OCTREOTIDE; PROPRANOLOL; PROPYLTHIOURACIL; SOMATOSTATIN DERIVATIVE; THIAMAZOLE; THYROTROPIN; THYROXINE;

BIOCHEMISTRY; CHOLELITHIASIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPERTHYROIDISM; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; THYROIDECTOMY; THYROTROPIN SECRETING ADENOMA; TRANSSPHENOIDAL SURGERY; ADENOMA; BIOLOGICAL MODEL; ENDOCRINE SYSTEM EXAMINATION; HYPERPITUITARISM; HYPOPHYSIS TUMOR; SECRETION;

ADENOMA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; HUMANS; HYPERPITUITARISM; MODELS, BIOLOGICAL; PITUITARY NEOPLASMS; THYROTROPIN;

EID: 72049120964     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2009.05.006     Document Type: Review

References (47)

1. Beck-Peccoz P., Brucker-Davis F., Persani L., et al. Thyrotropin-secreting pituitary tumors. Endocrine Reviews 17 (1996) 610-638
2. Beck-Peccoz P., and Persani L. TSH-producing adenomas. In: DeGroot L.J., and Jameson J.L. (Eds). Endocrinology. 5th edn. (2006), Elsevier Saundres, Philadelphia 475-484
3. Refetoff S., Weiss R.E., and Usala S.J. The syndromes of resistance to thyroid hormone. Endocrine Reviews 14 (1993) 348-399
4. Gurnell M., Beck-Peccoz P., and Chatterjee V.K. Resistance to thyroid hormone. In: DeGroot L.J., and Jameson J.L. (Eds). Endocrinology. 5th edn. (2006), Elsevier Saundres, Philadelphia 2227-2237
5. Kienitz T., Quinkler M., Strasburger C.J., et al. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. European Journal of Endocrinology 157 (2007) 39-46
6. Ness-Abramof R., Ishay A., Harel G., et al. TSH-secreting pituitary adenomas. Pituitary 10 (2007) 307-310
7. Foppiani L., Del Monte P., Ruelle A., et al. TSH-secreting adenomas: rare pituitary tumors with multifaceted clinical and biological features. Journal of Endocrinological Investigation 30 (2007) 603-609
8. Clarke M.J., Erickson D., Castro M.R., et al. Thyroid-stimulating pituitary adenomas. Journal of Neurosurgery 109 (2008) 17-22
9. Gershengorn M.C., and Weintraub B.D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". The Journal of Clinical Investigation 56 (1975) 633-642
10. Mixson A.J., Friedman T.C., David A.K., et al. Thyrotropin-secreting pituitary carcinoma. The Journal of Clinical Endocrinology and Metabolism 76 (1993) 529-533
11. Brown R.L., Muzzafar T., Wollman R., et al. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. European Journal of Endocrinology 154 (2006) 639-643
12. Cohen L.E., and Radovick S. Molecular bases of pituitary hormone deficiencies. Endocrine Reviews 23 (2002) 431-442
13. Mantovani G., Asteria C., Pellegrini C., et al. HESX1 expression in human normal pituitaries and pituitary adenomas. Molecular and Cellular Endocrinology 247 (2006) 135-139
14. Ma W., Ikeda H., Watabe N., et al. A plurihormonal TSH-producing pituitary tumor of monoclonal origin in a patient with hypothyroidism. Hormone Research 59 (2003) 257-261
15. Dong Q., Brucker-Davis F., Weintraub B.D., et al. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the Gαq, Gα11, Gαs, or thyrotropin-releasing hormone receptor genes. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 1134-1140
16. Asteria C., Anagni M., Persani L., et al. Loss of heterozigosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas. Journal of Endocrinological Investigation 24 (2001) 796-801
17. Ando S., Sarlis N.J., Krishnan J., et al. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Molecular Endocrinology 15 (2001) 1529-1538
18. Ando S., Sarlis N.J., Oldfield E.H., et al. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 5572-5576
19. Lu C., Willingham M.C., Furuya F., et al. Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyrois-stimulating hormone-secreting pituitary tumors. Endocrinology 149 (2008) 3339-3345
20. Horiguchi K., Yamada M., Umezawa R., et al. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment. Endocrine Journal 54 (2007) 371-378
21. Filopanti M., Ballaré E., Lania A.G., et al. Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas. Journal of Endocrinological Investigation 27 (2004) 937-942
22. Ezzat S., Horvath E., Kovacs K., et al. Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocrine Pathology 6 (1995) 125-134
23. Brucker-Davis F., Oldfield E.H., Skarulis M.C., et al. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 476-486
24. Langlois M.F., Lamarche J.B., and Bellabarba D. Long-standing goiter and hypothyroidism: an unusual presentation of a TSH-secreting adenoma. Thyroid 6 (1996) 329-335
25. Idiculla J.M., Beckett G., Statham P.F.X., et al. Autoimmune hypothyroidism coexisting with a pituitary adenoma secreting thyroid-stimulating hormone, prolactin and α-subunit. Annals of Clinical Biochemistry 38 (2001) 566-571
26. Losa M., Mortini P., Minelli R., et al. Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism. Journal of Endocrinological Investigation 29 (2006) 555-559
27. Gasparoni P., Rubello D., Persani L., et al. Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma. Thyroid 8 (1998) 181-183
28. Ohta S., Nishizawa S., Oki Y., et al. Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid: a case report and surgical strategy. Pituitary 4 (2001) 271-274
29. Abs R., Stevenaert A., and Beckers A. Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. European Journal of Endocrinology 131 (1994) 355-358
30. Kourides I.A., Pekonen F., and Weintraub B.D. Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism. The Journal of Clinical Endocrinology and Metabolism 51 (1980) 272-274
31. Socin H.V., Chanson P., Delemer B., et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. European Journal of Endocrinology 148 (2003) 433-442
32. Terzolo M., Orlandi F., Bassetti M., et al. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin. The Journal of Clinical Endocrinology and Metabolism 72 (1991) 415-421
33. Persani L., Preziati D., Matthews C.H., et al. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Clinical Endocrinology 47 (1997) 207-214
34. Bertherat J., Brue T., Enjalbert A., et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. The Journal of Clinical Endocrinology and Metabolism 75 (1992) 540-546
35. Gancel A., Vuillermet P., Legrand A., et al. Effets of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clinical Endocrinology 40 (1994) 421-428
36. Chanson P., Weintraub B.D., and Harris A.G. Octreotide therapy for thyroid stimulating-secreting pituitary adenomas. A follow-up of 52 patients. Annals of Internal Medicine 119 (1993) 236-240
37. Kuhn J.M., Arlot S., Lefebvre H., et al. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 1487-1491
38. Mannavola D., Persani L., Vannucchi G., et al. Different response to chronic somatostatin analogues in patients with central hyperthyroidism. Clinical Endocrinology 62 (2005) 176-181
39. Losa M., Magnani P., Mortini P., et al. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels. European Journal of Nuclear Medicine 24 (1997) 728-731
40. Cooper D.S., and Wenig B.M. Hyperthyroidism caused by an ectopic TSH-secreting pituitary tumor. Thyroid 6 (1996) 337-343
41. Pasquini E., Faustini-Fustini M., Sciarretta V., et al. Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. European Journal of Endocrinology 148 (2003) 253-257
42. Webster J., Peters J.R., John R., et al. Pituitary stone: two cases of densely calcified thyrotropin-secreting pituitary adenomas. Clinical Endocrinology 40 (1994) 137-143
43. Losa M., Giovanelli M., Persani L., et al. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 3086-3090
44. Ohki M., Sato K., Tuchiya D., et al. A case of TSH-secreting pituitary adenoma associated with an unruptured aneurysm: successful treatment by two-stage operation and gamma knife. No To Shinkei 51 (1999) 895-899
45. Rocheville M., Lange D.C., Kumar U., et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288 (2000) 154-157
46. Blackhurst G., Strachan M.W., Collie D., et al. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clinical Endocrinology 57 (2002) 401-404
47. Chaiamnuay S., Moster M., Katz M.R., et al. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary 6 (2003) 109-113